Vor Bio
Vor Bio is hiring a Senior Clinical Trial Associate to support study teams advancing telitacicept, a dual BAFF/APRIL inhibitor, across autoimmune disease indications. The role sits within Vor’s clinical operations environment and partners closely with Clinical Operations leaders to help enable smooth execution of trials from start-up through close.
Vor Bio is a clinical-stage cell and genome engineering company developing novel hematopoietic stem cell-based therapies for cancer. The company is focused on transforming the treatment of hematological malignancies through engineered stem cell transplantation and targeted therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vor Bio.
Vor, with new CEO, changes course to target autoimmune disease
Jun 26, 2025